ImmunityBio reports Q1 revenue of $44 million, up 168% year-over-year

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/5/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. GWRE
10. CIEN

Go back to ImmunityBio reports Q1 revenue of $44 million, up 168% year-over-year
(NASDAQ: IBRX) Delayed: 8.08 -0.11 (1.34%)
Previous Close $8.19    52 Week High $ 
Open $8.08    52 Week Low $ 
Day High $8.24    P/E N/A 
Day Low $8.01    EPS $ 
Volume 4,330,068